Weekly Analysts’ Ratings Updates for Colgate-Palmolive (CL)

Several analysts have recently updated their ratings and price targets for Colgate-Palmolive (NYSE: CL):

• 10/9/2026 – Colgate-Palmolive had its price target lowered by Bank of America Corporation from $102.00 to $100.00. They now have a “buy” rating on the stock.
• 10/8/2026 – Colgate-Palmolive had its price target raised by Evercore Inc from $100.00 to $101.00. They now have an “outperform” rating on the stock.
• 10/5/2026 – Colgate-Palmolive had its price target lowered by Wells Fargo & Company from $95.00 to $90.00. They now have an “equal weight” rating on the stock.
• 10/2/2026 – Colgate-Palmolive was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 9/28/2026 – Colgate-Palmolive had its price target lowered by BNP Paribas Exane from $101.00 to $97.00. They now have an “outperform” rating on the stock.
• 9/21/2026 – Colgate-Palmolive had its price target lowered by Piper Sandler from $98.00 to $95.00. They now have an “overweight” rating on the stock.
• 9/16/2026 – Colgate-Palmolive was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 9/8/2026 – Colgate-Palmolive had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $104.00 price target on the stock.
• 8/13/2026 – Colgate-Palmolive had its “market perform” rating reaffirmed by Sanford C. Bernstein.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s payout ratio is 84.13%.

Insider Transactions at Colgate-Palmolive

In other news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 175,191 shares of company stock worth $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.